The Enterprise Value as of September 2024 (TTM) for Aquestive Therapeutics, Inc. (AQST) is 407.64M

According to Aquestive Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 407.64M. This represents a change of 79.94% compared to the average of 226.54M of the last 4 quarters.

Aquestive Therapeutics, Inc. (AQST) Historical Enterprise Value (quarterly & annually)

How has AQST Enterprise Value performed in the past?

The mean historical Enterprise Value of Aquestive Therapeutics, Inc. over the last ten years is 210.53M. The current 407.64M Enterprise Value has changed 19.26% with respect to the historical average. Over the past ten years (40 quarters), AQST's Enterprise Value was at its highest in in the June 2018 quarter at 420.99M. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.

Aquestive Therapeutics, Inc. (AQST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aquestive Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aquestive Therapeutics, Inc. (AQST) Average Enterprise Value

How has AQST Enterprise Value performed in the past?

The current Enterprise Value of Aquestive Therapeutics, Inc. (AQST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aquestive Therapeutics, Inc. (AQST) Enterprise Value vs. Peers

How is AQST’s Enterprise Value compared to its peers?

Aquestive Therapeutics, Inc.’s Enterprise Value is greater than Evoke Pharma, Inc. (-1007253.00), greater than Adamis Pharmaceuticals Corporation (-6593458674.00), greater than Guardion Health Sciences, Inc. (2.19M), greater than AcelRx Pharmaceuticals, Inc. (1.19M), less than Dynavax Technologies Corporation (1.59B), less than Amphastar Pharmaceuticals, Inc. (2.64B), less than Lantheus Holdings, Inc. (6.94B), less than ANI Pharmaceuticals, Inc. (1.34B), less than Ironwood Pharmaceuticals, Inc. (1.26B), less than Alkermes plc (4.26B), greater than Eagle Pharmaceuticals, Inc. (110.03M), greater than Shuttle Pharmaceuticals Holdings, Inc. (3.88M), less than Mallinckrodt plc (2.62B), greater than Agile Therapeutics, Inc. (7.87M), greater than Lifecore Biomedical, Inc. (269.28M), greater than Organogenesis Holdings Inc. (347.97M), greater than Lucy Scientific Discovery Inc. (2.06M), greater than Alimera Sciences, Inc. (363.67M),

Build a custom stock screener for Aquestive Therapeutics, Inc. (AQST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aquestive Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aquestive Therapeutics, Inc. (AQST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aquestive Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.